Capstone Investment Advisors, LLC Bausch Health Companies Inc. Call Options Transaction History

Capstone Investment Advisors, LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2020 Feb 16, 2021	SELL	$15.31 - $21.12 $2.48 Million - $3.42 Million	-162,100 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$14.88 - $20.13 $2.41 Million - $3.26 Million	162,100 New	162,100 $2.52 Million
Q4 2019 Feb 14, 2020	SELL	$18.89 - $31.89 $855,717 - $1.44 Million	-45,300 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$20.88 - $25.66 $1.49 Million - $1.83 Million	-71,500 Reduced 61.22%	45,300 $990,000
Q2 2019 Aug 14, 2019	BUY	$20.52 - $26.45 $2.4 Million - $3.09 Million	116,800 New	116,800 $2.95 Million

254

253M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.7B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Capstone Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Capstone Investment Advisors, LLC with notifications on news.